一个黑色细胞谱系程序赋予了对MAP激酶途径抑制的耐药性
Cory M Johannessen1, Laura A Johnson, Federica Piccioni
11] The Broad Institute of Harvard University and Massachusetts Institute of Technology, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA [2] Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115, USA [3] Harvard Medical School, 25 Shattuck Street, Boston, Massachusetts 02115, USA.
Nature
|November 5, 2013
概括
BRAF (V600E) 黑色素瘤依赖于RAF-MEK-ERK信号传递. 研究人员确定了一条涉及CREB的cAMP依赖途径,该途径驱动对向疗法的耐药性,建议结合治疗以提高疗效.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 具有BRAF (V600E) 突变的恶性黑色素瘤取决于RAF-MEK-ERK信号传输.
- RAF和MEK抑制剂是有效的,但面临的阻力挑战.
研究的目的:
- 在BRAF (V600E) 黑色素瘤中对抗性机制进行全球性表征.
- 确定新的治疗点和组合来克服药物耐药性.
主要方法:
- 系统性功能增益抗性研究涉及超过15500个基因的表达.
- 用RAF,MEK,ERK或联合RAF-MEK抑制剂治疗BRAF (V600E) 黑色素瘤细胞系.
- 对患者活检的分析,以评估CREB在复发瘤中的活性.
主要成果:
- 包括CREB在内的循环AMP依赖的黑色素细胞信号网络被确定为抵抗的驱动因素.
- 化CREB被RAF-MEK抑制抑制,但在复发瘤中恢复.
- 像c-FOS,NR4A1,NR4A2和MITF这样的转录因子也赋予了耐药性.
结论:
- 黑色细胞系依赖的瘤性失调可以导致对RAF-MEK-ERK抑制剂的耐药性.
- 将MAPK路径抑制剂与基因素脱乙酶抑制剂结合起来,可以克服MITF和cAMP介导的抗性.
相关概念视频
MAPK Signaling Cascades
7.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.4K
Interactions Between Signaling Pathways
4.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The Intrinsic Apoptotic Pathway
6.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K


